EstechPharma Co (041910) Fair Value & Analysis
Healthcare · KR · Market cap 73.6B KRW
Fair value as of: Jun 24, 2026
Analysis
EstechPharma Co (041910) currently trades at 4,645 KRW, while our model-based Fair Value estimate is 8,679 KRW — implying the stock looks roughly 86.8% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
EstechPharma Co., Ltd. manufactures and sells pharmaceuticals products. It also offers raw materials, such as RBM and PLK. The company was formerly known as Estech Chemical and changed its name to EstechPharma Co., Ltd. in January 2001. EstechPharma Co., Ltd. was founded in 1996 and is headquartered in Hwaseong-si, South Korea.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is EstechPharma Co (041910) undervalued?
What is the fair value of 041910?
What is the quality score of 041910?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.